• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Feb 24, 2023 at 09:12: AM
via British drugmaker GSK's HIV treatment division, ViiV Healthcare, published data on Wednesday showing its long-acting HIV injection is as effective as the market-leading daily pill made by Gilead Sciences Inc.

article source
 




Top Bottom
Back
Quote